BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 23043475)

  • 1. Ask the experts: the challenges and benefits of flow chemistry to optimize drug development.
    Anderson N; Gernaey KV; Jamison TF; Kircher M; Wiles C; Leadbeater NE; Sandford G; Richardson P
    Future Med Chem; 2012 Sep; 4(14):1779-89. PubMed ID: 23043475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ask the experts: future of the pharmaceutical industry. Interview by Future Medicinal Chemistry.
    Cottens S; Eaton M; Fuhr J; Geary S; Johnson DS; Li G; Raveglia L; Robertson GM; Westwell A
    Future Med Chem; 2011 Nov; 3(15):1863-72. PubMed ID: 22023030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addressing the medicinal chemistry bottleneck: a lean approach to centralized purification.
    Weller HN; Nirschl DS; Paulson JL; Hoffman SL; Bullock WH
    ACS Comb Sci; 2012 Sep; 14(9):520-6. PubMed ID: 22909004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug discovery chemistry: a primer for the non-specialist.
    Jordan AM; Roughley SD
    Drug Discov Today; 2009 Aug; 14(15-16):731-44. PubMed ID: 19416759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Process R&D under the magnifying glass: organization, business model, challenges, and scientific context.
    Federsel HJ
    Bioorg Med Chem; 2010 Aug; 18(16):5775-94. PubMed ID: 20621486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vertical disintegration: a strategy for pharmaceutical businesses in 2009?
    Dixon J; Lawton G; Machin P
    Nat Rev Drug Discov; 2009 Jun; 8(6):435. PubMed ID: 19483701
    [No Abstract]   [Full Text] [Related]  

  • 7. In search of sustainability: process R&D in light of current pharmaceutical industry challenges.
    Federsel HJ
    Drug Discov Today; 2006 Nov; 11(21-22):966-74. PubMed ID: 17055405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ROCK: the Roche medicinal chemistry knowledge application - design, use and impact.
    Mayweg A; Hofer U; Schnider P; Agnetti F; Galley G; Mattei P; Lucas M; Boehm HJ
    Drug Discov Today; 2011 Aug; 16(15-16):691-6. PubMed ID: 21439402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How should we support pharmaceutical innovation?
    Grootendorst P
    Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):313-20. PubMed ID: 19670991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Drug Discovery Portal: a resource to enhance drug discovery from academia.
    Clark RL; Johnston BF; Mackay SP; Breslin CJ; Robertson MN; Harvey AL
    Drug Discov Today; 2010 Aug; 15(15-16):679-83. PubMed ID: 20547242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global medicinal chemistry and GPCR conference: interview with Stevan Djuric.
    Djuric S
    Future Med Chem; 2018 Apr; 10(8):837-838. PubMed ID: 29580099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competition: Unlikely partnerships.
    Savage N
    Nature; 2016 May; 533(7602):S56-8. PubMed ID: 27167391
    [No Abstract]   [Full Text] [Related]  

  • 13. Embedding sustainable practices into pharmaceutical R&D: what are the challenges?
    Sneddon H
    Future Med Chem; 2014; 6(12):1373-6. PubMed ID: 25329193
    [No Abstract]   [Full Text] [Related]  

  • 14. Interview with Future Medicinal Chemistry's US Senior Editor, Iwao Ojima. Interview by Issac Bruce.
    Ojima I
    Future Med Chem; 2012 Oct; 4(16):2019-22. PubMed ID: 23157234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The economics of pediatric formulation development for off-patent drugs.
    Milne CP; Bruss JB
    Clin Ther; 2008 Nov; 30(11):2133-45. PubMed ID: 19108801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prologue: chirality in the pharmaceutical industry.
    Caldwell J; Berova N; McConnell O
    Chirality; 2007 Sep; 19(9):657. PubMed ID: 17657706
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug discovery: new models for industry-academic partnerships.
    Tralau-Stewart CJ; Wyatt CA; Kleyn DE; Ayad A
    Drug Discov Today; 2009 Jan; 14(1-2):95-101. PubMed ID: 18992364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Portfolio management in early stage drug discovery - a traveler's guide through uncharted territory.
    Betz UA
    Drug Discov Today; 2011 Jul; 16(13-14):609-18. PubMed ID: 21600301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for bringing drug delivery tools into discovery.
    Kwong E; Higgins J; Templeton AC
    Int J Pharm; 2011 Jun; 412(1-2):1-7. PubMed ID: 21421040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicinal chemistry at a crossroads: challenges and new possibilities.
    Ojima I
    Future Med Chem; 2009 Jun; 1(3):401-3. PubMed ID: 21426118
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.